All rights reserved, Copyright 2022 PALTAC CORPORATION Management Planning Headquarters
Financial Results FY2022/3
All rights reserved, Copyright 2022 PALTAC CORPORATION Management Planning Headquarters
2
FY2022/3 Results (vs. Plan)
Both sales and profits were below plan
Owing to deteriorating market conditions due to such factor as the spread of infections
FY2022/3
¥ billion
FY2022/3
(After application of "Accounting Standard for Revenue Recognition" , etc.)
(ratio of net sales：%)
Plan
Results
Difference
Main factors
Net Sales
1,060.0
1,045.7
-14.2
Sales of cosmetics and OTC pharmaceuticals
were lower than forecast due to the spread of
infections
Gross Profit
83.0
81.7
-1.2
Demand for hygiene products with high gross
(7.83)
(7.82)
(-0.01)
profit margin was lower than expectation
SG&A expenses
56.5
55.8
-0.6
Effect of absorbing fixed costs decreased
(5.33)
(5.34)
(+0.01)
due to shortfalls in sales
Operating Profit
26.5
25.9
-0.5
(2.50)
(2.48)
(-0.02)
29.0
28.6
-0.3
Despite initiatives to improve gross profit and
Ordinary Profit
SG&A expenses, all profit items from operating
(2.74)
(2.74)
(+0.00)
profit onwards were lower than plan due to
shortfalls in sales
Profit
20.0
19.6
-0.3
(1.89)
(1.88)
(-0.01)
All rights reserved, Copyright 2022 PALTAC CORPORATION Management Planning Headquarters
3
FY2022/3 Results (vs. Plan)
The spread of COVID-19 far exceeded the level which
the Company used as initial assumption to set the plan in around April 2021
Sales struggled due to slower recovery of demand for cosmetics and OTC pharmaceuticals
Sixth wave's peak
(about 20 times compared to that number as of April 2021)
Trend in the number of newly confirmed cases (monthly)
Fifth wave's peak
(about 5 times compared to that number as of April 2021)
Assumption of
the plan
Reference data : Ministry of Health, Labour and Welfare HP "Domestic outbreak situation"
All rights reserved, Copyright 2022 PALTAC CORPORATION Management Planning Headquarters
4
FY2022/3 Results (YoY)
Net sales, operating profit and ordinary profit achieved the highest levels
FY2022/3
FY2022/3
Impact of
(After application of "Accounting
（Application of the accounting standards
¥ billion
FY2021/3
changes
Standard for Revenue Recognition" , etc.)
used in previous period）
(ratio of net sales：%)
①
Amount(YoY)
Rate(YoY)
②
Amount(YoY)
Rate(YoY)
①－②
Net Sales
1,033.2
1,045.7
+12.4
+1.2%
1,047.0
+13.7
+1.3%
-1.2
Gross Profit
81.1
81.7
+0.5
+0.7%
81.7
+0.5
+0.7%
+0.0
(7.85)
(7.82)
(-0.03)
(7.81)
(-0.04)
SG&A
55.6
55.8
+0.1
+0.3%
55.8
+0.1
+0.3%
-
expenses
(5.39)
(5.34)
(-0.05)
(5.33)
(-0.06)
Operating
25.4
25.9
+0.4
+1.7%
25.9
+0.4
+1.6%
+0.0
Profit
(2.47)
(2.48)
(+0.01)
(2.47)
(+0.00)
Ordinary
28.0
28.6
+0.5
+2.1%
28.6
+0.5
+2.0%
+0.0
Profit
(2.71)
(2.74)
(+0.03)
(2.73)
(+0.02)
Profit
19.3
19.6
+0.3
+1.7%
19.6
+0.3
+1.6%
+0.0
(1.87)
(1.88)
(+0.01)
(1.87)
(+0.00)
Note : From the beginning of the fiscal year under review, the Company has applied the "Accounting Standard for Revenue Recognition", etc.
All rights reserved, Copyright 2022 PALTAC CORPORATION Management Planning Headquarters
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Paltac Corporation published this content on 20 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2022 06:14:04 UTC.
PALTAC COPORATION is a Japan-based company mainly engaged in the wholesale of cosmetics, daily necessities and OTC (over-the-counter) drugs. The Company also provides logistics, inventory, information transmission, and finance business. The Company operates Wholesale segment.
PALTAC CORPORATION 
